Finance

Lists
6838:TPE
Formosa Pharmaceuticals Inc
NT$25,65
+0,59%
(+0,15) 1D
29 Sep., 13:30:15 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6838...
Open
NT$25,50
High
NT$26,25
Low
NT$25,45
Mkt. cap
3,87 mjd
Avg. vol.
141,54 k
Volume
274,77 k
52-wk high
NT$33,30
52-wk low
NT$22,35
EPS
-NT$1,26
No. of employees
10
Open
NT$25,50
High
NT$26,25
Low
NT$25,45
Mkt. cap
3,87 mjd
Avg. vol.
141,54 k
Volume
274,77 k
52-wk high
NT$33,30
52-wk low
NT$22,35
EPS
-NT$1,26
No. of employees
10
About Formosa Pharmaceuticals Inc
CEO-
Employees10
Founded2010
Headquarters-
SectorPharmaceutical industry
Websiteformosapharma.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
911,00 k
3,23 m
45,42 m
3,03 m
Cost of goods sold
6,11 m
2,72 m
5,93 m
7,67 m
Cost of revenue
6,11 m
2,72 m
5,93 m
7,67 m
Research and development expenses
25,25 m
30,71 m
40,14 m
61,69 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,16 m
9,18 m
10,00 m
9,36 m
Operating expense
39,41 m
39,89 m
50,14 m
71,05 m
Total operating expenses
45,52 m
42,61 m
56,07 m
78,72 m
Operating income
-44,61 m
-39,38 m
-10,65 m
-75,69 m
Other non operating income
-
-1,19 m
-
-24,00 k
EBT including unusual items
-59,29 m
-48,04 m
-15,00 m
-65,38 m
EBT excluding unusual items
-59,29 m
-48,04 m
-15,00 m
-65,38 m
Income tax expense
-123,00 k
-124,00 k
255,00 k
2,25 m
Effective tax rate
0,21%
0,26%
-1,70%
-3,44%
Other operating expenses
-
-
-
-
Net income
-59,19 m
-47,96 m
-15,26 m
-67,63 m
Net profit margin
-6 497,48%
-1 486,83%
-33,60%
-2 235,06%
Earnings per share
-
-
-
-
Interest and investment income
6,14 m
6,33 m
5,56 m
5,54 m
Interest expense
-128,00 k
-130,00 k
-130,00 k
-124,00 k
Net interest expenses
6,01 m
6,20 m
5,43 m
5,41 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-33,34 m
-28,03 m
727,00 k
-64,19 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme